| [1] |
GAO Y, TIAN M, HOU X, et al. Multifocality increases the risk of central compartment lymph node metastasis but is not related to the risk of recurrence and death in papillary thyroid carcinoma[J]. Gland Surg, 2024, 13(12): 2383-2394. doi:10.21037/gs-2024-505 .
doi: 10.21037/gs-2024-505
|
| [2] |
SHAO H, SUN Y, NA Z, et al. Diagnostic value of applying preoperative breast ultrasound and clinicopathologic features to predict axillary lymph node burden in early invasive breast cancer: A study of 1247 patients[J]. BMC Cancer, 2024, 24(1): 112. doi:10.1186/s12885-024-11853-2 .
doi: 10.1186/s12885-024-11853-2
|
| [3] |
WANG B, CAO Q, CUI X W, et al. A model based on clinical data and multi-modal ultrasound for predicting cervical lymph node metastasis in patients with thyroid papillary carcinoma[J]. Front Endocrinol, 2022, 13: 1063998. doi:10.3389/fendo.2022.1063998 .
doi: 10.3389/fendo.2022.1063998
|
| [4] |
ZHANG W, ZHU J, ZHANG Y, et al. Personalized prediction of lymph node metastasis in papillary thyroid microcarcinoma: A nomogram and web calculator[J]. Sci Rep, 2025, 15(1): 45288. doi:10.1038/s41598-025-28483-8 .
doi: 10.1038/s41598-025-28483-8
|
| [5] |
朱枫, 李青, 陈曦, 等. 细针穿刺活检联合高通量测序技术在甲状腺结节诊疗中的应用[J]. 实用医学杂志, 2024, 40(17): 2471-2476. doi:10.3969/j.issn.1006-5725.2024.17.020 .
doi: 10.3969/j.issn.1006-5725.2024.17.020
|
| [6] |
余江涛, 王世杰, 张高飞, 等. 血清甲状腺球蛋白、促甲状腺激素联合检测对行甲状腺全切术后未接受清甲治疗的分化型甲状腺癌患者复发的预测价值[J]. 实用医学杂志, 2023, 39(9): 1159-1163. doi:10.3969/j.issn.1006-5725.2023.09.017 .
doi: 10.3969/j.issn.1006-5725.2023.09.017
|
| [7] |
TESSLER F N, MIDDLETON W D, GRANT E G, et al. ACR thyroid imaging, reporting and data system (TI-RADS): White paper of the ACR TI-RADS committee[J]. J Am Coll Radiol, 2017, 14(5): 587-595. doi:10.1016/j.jacr.2017.01.046 .
doi: 10.1016/j.jacr.2017.01.046
|
| [8] |
BALOCH Z W, ASA S L, BARLETTA J A, et al. Overview of the 2022 WHO classification of thyroid neoplasms[J]. Endocr Pathol, 2022, 33(1): 27-63. doi:10.1007/s12022-022-09707-3 .
doi: 10.1007/s12022-022-09707-3
|
| [9] |
RINGEL M D, SOSA J A, BALOCH Z, et al. 2025 American thyroid association management guidelines for adult patients with differentiated thyroid cancer[J]. Thyroid®, 2025, 35(8): 841-985. doi:10.1177/10507256251363120 .
doi: 10.1177/10507256251363120
|
| [10] |
HWANG H S, ORLOFF L A. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer[J]. Laryngoscope, 2011, 121(3): 487-491. doi:10.1002/lary.21227 .
doi: 10.1002/lary.21227
|
| [11] |
HUANG Y, LOU P, LI H, et al. Risk nomogram for papillary thyroid microcarcinoma with central lymph node metastasis and postoperative thyroid function follow-up[J]. Front Endocrinol, 2024, 15: 1395900. doi:10.3389/fendo.2024.1395900 .
doi: 10.3389/fendo.2024.1395900
|
| [12] |
LIU C, YANG S, XUE T, et al. The application of a clinical-multimodal ultrasound radiomics model for predicting cervical lymph node metastasis of thyroid papillary carcinoma[J]. Front Oncol, 2025, 14: 1507953. doi:10.3389/fonc.2024.1507953 .
doi: 10.3389/fonc.2024.1507953
|
| [13] |
LIN Y, CUI N, LI F, et al. The model for predicting the central lymph node metastasis in CN0 papillary thyroid microcarcinoma with Hashimoto’s thyroiditis[J]. Front Endocrinol, 2024, 15: 1330896. doi:10.3389/fendo.2024.1330896 .
doi: 10.3389/fendo.2024.1330896
|
| [14] |
许魁, 周军. 超声微泡在甲状腺癌诊疗中的研究进展[J]. 实用医学杂志, 2025, 41(3): 454-458. doi: 10.3969/j.issn.1006-5725.2025.03.023 .
doi: 10.3969/j.issn.1006-5725.2025.03.023
|
| [15] |
LU J, LIAO J, CHEN Y, et al. Risk factor analysis and prediction model for papillary thyroid carcinoma with lymph node metastasis[J]. Front Endocrinol, 2023, 14: 1287593. doi:10.3389/fendo.2023.1287593 .
doi: 10.3389/fendo.2023.1287593
|
| [16] |
ZHANG X Y, ZHANG D, ZHOU W, et al. Predicting lymph node metastasis in papillary thyroid carcinoma: Radiomics using two types of ultrasound elastography[J]. Cancer Imaging, 2025, 25(1): 13. doi:10.1186/s40644-025-00832-w .
doi: 10.1186/s40644-025-00832-w
|
| [17] |
WANG Y, TAN H L, DUAN S L, et al. Predicting central cervical lymph node metastasis in papillary thyroid microcarcinoma using deep learning[J]. PeerJ, 2024, 12: e16952. doi:10.7717/peerj.16952 .
doi: 10.7717/peerj.16952
|
| [18] |
CHEN L, CHEN L, LIANG Z, et al. Value of contrast-enhanced ultrasound in the preoperative evaluation of papillary thyroid carcinoma invasiveness[J]. Front Oncol, 2022, 11: 795302. doi:10.3389/fonc.2021.795302 .
doi: 10.3389/fonc.2021.795302
|
| [19] |
孙康, 汪晓明, 王建国. 甲状腺乳头状癌合并桥本甲状腺炎的临床特点[J]. 实用医学杂志, 2023, 39(13): 1641-1646. doi:10.3969/j.issn.1006-5725.2023.13.008 .
doi: 10.3969/j.issn.1006-5725.2023.13.008
|
| [20] |
ZHOU W, LI L, HAO X, et al. Predicting central lymph node metastasis in papillary thyroid microcarcinoma: A breakthrough with interpretable machine learning[J]. Front Endocrinol, 2025, 16: 1537386. doi:10.3389/fendo.2025.1537386 .
doi: 10.3389/fendo.2025.1537386
|
| [21] |
LIU W, WANG S, XIA X. Risk factor analysis for central lymph node metastasis in papillary thyroid microcarcinoma[J]. Int J Gen Med, 2021, 14: 9923-9929. doi:10.2147/IJGM.S346143 .
doi: 10.2147/IJGM.S346143
|
| [22] |
ZHONG L, XIE C, GAN X, et al. Hashimoto’s thyroiditis reduces central lymph node metastasis risk in papillary thyroid microcarcinoma: An integrated meta-analysis[J]. Front Endocrinol, 2025, 16: 1695508. doi:10.3389/fendo.2025.1695508 .
doi: 10.3389/fendo.2025.1695508
|